Sorry, your browser does not support JavaScript!
Find a Treatment Center
Investor Relations
Contact Us
About Us
Our Mission
Our Story
Therapeutic Areas
Leadership
Kite Locations
Cell Therapy
Our Cell Therapy Technology
Our Therapies
Pipeline
Trials & Expanded Access
Clinical Trial Diversity
External Research Program (ERP)
Patient Resources
Patient Stories
Our Authorized Treatment Centers
Kite Konnect
Newsroom
Newsroom
Press Releases
Company Statements
Media Kit
Careers
Careers
Veteran Careers
Early Talent Programs
Culture & Benefits
Utility
Investor Relations
Contact Us
Kite Konnect®
Contact Us
Find a Treatment Center
Investor Relations
Press Releases
Filter By Year
2024
2023
2022
2021
2020
2019
2018
2017
2024
January 30, 2024
Kite Receives U.S. FDA Approval of Manufacturing Process Change Resulting in Reduced Median Turnaround Time for Yescarta® CAR T-cell Therapy
Filter By Year
2024
2023
2022
2021
2020
2019
2018
2017